CRYO Cryo-Save

 

TIDMCRYO 
 
RNS Number : 4258J 
Cryo-Save Group NV 
30 March 2010 
 

30 March 2010 
 
Cryo-Save Group N.V 
 
Director/PDMR Shareholding 
 
Cryo-Save Group N.V.(AIM/Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's 
leading stem cell bank, has been informed today that Mr Johan Goossens, 
Chairman, purchased 17,873 ordinary shares of Euro 0.10 ('Ordinary Shares') at a 
price range between EUR5.60 and EUR5.84 between 23 March and 26 March 2010. 
 
Following these purchases, Johan Goossens is beneficially interested in 
1,630,000 ordinary shares, representing approximately 17.65% of the Group's 
issued share capital. 
 
Enquiries: 
 
+------------------------------------+----------------------+ 
| Cryo-Save Group                    |  +  31 (0)575 548998 | 
+------------------------------------+----------------------+ 
| Marc Waeterschoot, Chief Executive |                      | 
| Officer                            |                      | 
+------------------------------------+----------------------+ 
| Arnoud van Tulder, Chief Financial |                      | 
| Officer                            |                      | 
+------------------------------------+----------------------+ 
|                                    |                      | 
+------------------------------------+----------------------+ 
| Daniel Stewart & Company plc       |     + 44 (0) 20 7776 | 
|                                    |                 6550 | 
+------------------------------------+----------------------+ 
| Simon Leathers/Emma Earl           |                      | 
+------------------------------------+----------------------+ 
|                                    |                      | 
+------------------------------------+----------------------+ 
| College Hill (UK)                  |     + 44 (0) 20 7457 | 
|                                    |                 2020 | 
+------------------------------------+----------------------+ 
| Adrian Duffield/Rozi Morris        |                      | 
+------------------------------------+----------------------+ 
|                                    |                      | 
+------------------------------------+----------------------+ 
| SPJ Financiële Communicatie Amstelveen (NL)               | 
| +31 (0)20 647 8181                                        | 
+-----------------------------------------------------------+ 
| Kees Jongsma/Léon Melens           |                      | 
+------------------------------------+----------------------+ 
 
About Cryo-Save 
 
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in 
Europe and one of the fastest growing in the world. Driven by its international 
business strategy, Cryo-Save is now represented in 38 countries on three 
continents and has state-of-the-art processing facilities in Belgium, Germany, 
Dubai, India and France (under construction). 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSLLFELVDIIVII 
 

Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025

Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025